World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
about
The role of lamotrigine in the management of bipolar disorderThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelinesThe International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of GuidelinesThe noradrenergic action in antidepressant treatments: pharmacological and clinical aspectsMono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSPQuetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depressionThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.Korean Medication Algorithm Project for Bipolar Disorder: third revision.Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.Effects of different antidepressant treatments on the core of depression.The pharmacogenomics of selective serotonin reuptake inhibitors.Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Clinical profile and outcome of bipolar disorder patients receiving electroconvulsive therapy: a study from north India.Pharmacotherapy for the treatment of acute bipolar II depression: current evidenceMedication use, service utilization, and medical costs associated with new episodes of bipolar disorder: evidence from a retrospective claims databaseTreatment of bipolar disorder: a complex treatment for a multi-faceted disorder.Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review.A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?The serotonin transporter gene and effectiveness of SSRIs.Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care serviceDifferent neural responses to a moral valence decision task in unipolar and bipolar depression.Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature.Is lithium in a class of its own? A brief profile of its clinical use.Epilepsy and bipolar disorders.Lithium for bipolar disorder: a review of the recent literature.How close is evidence to truth in evidence-based treatment of mental disorders?Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis.Treating bipolar depression - antidepressants and alternatives: a critical review of the literature.Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report.
P2860
Q24658110-D2ABDF31-E0C8-49CC-9605-EC1A7D24CD49Q28066714-38D3D2A6-0741-444D-A238-BCCE6494AB98Q28069743-8F583867-7B2B-4023-AED7-66E7B9599445Q28076486-ABE8F531-CCDE-4E9F-A609-42BC2350DB4EQ28300843-31DAB2E5-80D4-452C-B5ED-D98DBE5C5FA0Q30569917-A137686B-81CD-4A11-9AFB-F2A3FFD0A8C7Q31127921-74EF9BA2-FB9F-4A06-88F3-D5684CA5A5CEQ33518859-EC08E8D6-67F1-45FA-B2B4-8177B51CDC28Q33959019-115AE42E-803A-4211-9189-B3E36E6568B4Q34518033-2A4336C3-0ED4-401B-A1CF-1EA1ABCE2F6DQ34531273-6D32CF0D-7BEC-41C0-B659-D347F1E0C628Q34547920-8474B1E2-4F2C-4502-88F5-EA06D10C9B57Q34550618-F47050C4-6F97-4634-A49B-4F42D5A275D6Q34578945-F1F5D12E-2289-4FE6-B724-B46B0929CD66Q34606256-42A2155A-09C0-48AD-B299-1B1EC2B2ED16Q34616633-AF396D86-54A1-4279-B93C-3BA8133D886DQ35142737-53FAA340-84D6-4A92-AFA4-47BA0C733406Q35180787-C4CD88B5-F7C9-464E-95E8-A28275429934Q35237015-7C8B56C0-DAAB-4939-8191-0C88E318240FQ35757723-734C1B8D-03F0-4AA8-9446-6E9EEA1477C0Q35822006-83DA4829-270B-4BB1-B7B9-9CD41799F84CQ35862776-4CA9970E-B8A2-4510-B515-7EA3B84EE90EQ35919586-B3D24831-6713-4056-9427-BF35C076F535Q35954969-27364AFC-0B57-4F44-A2D1-2AA85F7FB5CCQ36060007-BD28AE8F-0D70-4DA6-8D62-9BF1C7589229Q36162402-4CBDD911-F2B9-4FF0-B298-FC7133042D1CQ36307086-D1944B89-3E5A-4274-825C-56AAC33A74FEQ36560064-DC83E757-B487-4701-8BE9-5FD854DB2AA0Q36836763-9A44AD85-66D4-4106-8A1F-58E62F91F300Q37035245-3861830D-977C-4562-B0AC-C9F2B83EC05BQ37115466-A15160B8-5BCB-4803-B33E-C386B20738A4Q37424287-C934A162-92A6-475B-91B7-C371FF8EE540Q37648736-195B255F-E70F-48B2-9F99-F90288085EACQ37650273-557D8F98-4506-45CF-B8DF-045C17F8EC73Q37658892-C8F13B8C-174B-4178-ABFE-6C053E23CAADQ38240532-011CC6D7-2BF8-42B5-BEE5-979D4641EE42Q38480790-547516A3-0DF9-4EF1-AEBF-D8EACF72D207Q38536939-9C93F9D7-A087-4CF8-9D00-F573572DC526Q38764892-4C4A1950-BFBC-4A2D-8C43-33FCDA547470Q38904156-345DAA27-F203-4F28-91D3-28E325196F31
P2860
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
World Federation of Societies ...... eatment of bipolar depression.
@ast
World Federation of Societies ...... eatment of bipolar depression.
@en
type
label
World Federation of Societies ...... eatment of bipolar depression.
@ast
World Federation of Societies ...... eatment of bipolar depression.
@en
prefLabel
World Federation of Societies ...... eatment of bipolar depression.
@ast
World Federation of Societies ...... eatment of bipolar depression.
@en
P2093
P2860
P50
P1476
World Federation of Societies ...... eatment of bipolar depression.
@en
P2093
Charles Bowden
David Baldwin
Guy Goodwin
Rasmus Licht
World Federation of Societies ...... idelines for Bipolar Disorders
P2860
P304
P356
10.3109/15622970209150612
P577
2002-07-01T00:00:00Z